CytomX Therapeutics Presents CX-072 Clinical Translational Data at 2018 SITC Annual Meeting

World News: . []

SOUTH SAN FRANCISCO Calif Nov 09 2018 GLOBE NEWSWIRE -- LINK  Therapeutics Inc Nasdaq CTMX a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational LINK  therapeutics based on its Probody...

More news and information about CytomX Therapeutics Inc.

Published By:

Globe Newswire: 13:00 GMT Friday 9th November 2018

Published: .

Search for other references to "cytomx" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us